<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
   <front>
      <journal-meta>
         <journal-id journal-id-type="publisher-id">STD</journal-id>
         <journal-id journal-id-type="hwp">spstd</journal-id>
         <journal-title>International Journal of STD &amp; AIDS</journal-title>
         <issn pub-type="ppub">0956-4624</issn>
         <issn pub-type="epub">1758-1052</issn>
         <publisher>
            <publisher-name>SAGE Publications</publisher-name>
            <publisher-loc>Sage UK: London, England</publisher-loc>
         </publisher>
      </journal-meta>
      <article-meta>
         <article-id pub-id-type="doi">10.1177/0956462412472316</article-id>
         <article-id pub-id-type="publisher-id">10.1177_0956462412472316</article-id>
         <article-categories>
            <subj-group subj-group-type="heading">
               <subject>Original research articles</subject>
            </subj-group>
         </article-categories>
         <title-group>
            <article-title>Liver involvement in HIV-infected patients with early syphilis</article-title>
         </title-group>
         <contrib-group>
            <contrib contrib-type="author" xlink:type="simple">
               <name name-style="western">
                  <surname>Palacios</surname>
                  <given-names>R</given-names>
               </name>
               <degrees>MD PhD</degrees>
               <xref ref-type="aff" rid="af1">*</xref>
               <xref ref-type="aff" rid="af2">†</xref>
               <xref ref-type="corresp" rid="cor1"/>
            </contrib>
            <contrib contrib-type="author" xlink:type="simple">
               <name name-style="western">
                  <surname>Navarro</surname>
                  <given-names>F</given-names>
               </name>
               <degrees>MD</degrees>
               <xref ref-type="aff" rid="af1">*</xref>
            </contrib>
            <contrib contrib-type="author" xlink:type="simple">
               <name name-style="western">
                  <surname>Narankiewicz</surname>
                  <given-names>D</given-names>
               </name>
               <degrees>MD</degrees>
               <xref ref-type="aff" rid="af3">‡</xref>
            </contrib>
            <contrib contrib-type="author" xlink:type="simple">
               <name name-style="western">
                  <surname>Marcos</surname>
                  <given-names>M</given-names>
               </name>
               <degrees>MD</degrees>
               <xref ref-type="aff" rid="af4">§</xref>
            </contrib>
            <contrib contrib-type="author" xlink:type="simple">
               <name name-style="western">
                  <surname>Jiménez-Oñate</surname>
                  <given-names>F</given-names>
               </name>
               <degrees>MD</degrees>
               <xref ref-type="aff" rid="af2">†</xref>
               <xref ref-type="aff" rid="af3">‡</xref>
            </contrib>
            <contrib contrib-type="author" xlink:type="simple">
               <name name-style="western">
                  <surname>de la Torre</surname>
                  <given-names>J</given-names>
               </name>
               <degrees>MD PhD</degrees>
               <xref ref-type="aff" rid="af4">§</xref>
            </contrib>
            <contrib contrib-type="author" xlink:type="simple">
               <name name-style="western">
                  <surname>Santos</surname>
                  <given-names>J</given-names>
               </name>
               <degrees>MD PhD</degrees>
               <xref ref-type="aff" rid="af1">*</xref>
               <xref ref-type="aff" rid="af2">†</xref>
            </contrib>
         </contrib-group>
         <aff id="af1">
            <label>*</label>
            <institution xlink:type="simple">UGC de Enfermedades Infecciosas, Hospital Virgen de la Victoria</institution>
         </aff>
         <aff id="af2">
            <label>†</label>
            <institution xlink:type="simple">Instituto de Investigación Biomédica de Málaga (IBIMA)</institution>
         </aff>
         <aff id="af3">
            <label>‡</label>
            <institution xlink:type="simple">Servicio de Enfermedades Infecciosas, Hospital Carlos Haya</institution>, <addr-line>Málaga</addr-line>
         </aff>
         <aff id="af4">
            <label>§</label>
            <institution xlink:type="simple">Sección de Enfermedades Infecciosas, Servicio de Medicina Interna, Hospital Costa del Sol</institution>, <addr-line>Marbella</addr-line>, <country>Spain</country>
         </aff>
         <author-notes>
            <corresp id="cor1">
               <bold>Correspondence to:</bold> Rosario Palacios Muñoz, <institution xlink:type="simple">UGC de Enfermedades Infecciosas, Hospital Virgen de la Victoria</institution>, <addr-line>Campus Teatinus s/n, 29010 Malaga</addr-line>, <country>Spain</country> Email: <email xlink:type="simple">med006809@saludalia.com</email>
            </corresp>
         </author-notes>
         <pub-date pub-type="epub-ppub">
            <month>1</month>
            <year>2013</year>
         </pub-date>
         <volume>24</volume>
         <issue>1</issue>
         <fpage>31</fpage>
         <lpage>33</lpage>
         <history>
            <date date-type="accepted">
               <day>17</day>
               <month>6</month>
               <year>2012</year>
            </date>
         </history>
         <permissions>
            <copyright-statement>© SAGE Publications Ltd, 2013</copyright-statement>
            <copyright-year>2013</copyright-year>
            <copyright-holder content-type="sage">SAGE Publications</copyright-holder>
         </permissions>
         <abstract>
            <p>The aim of the paper is to analyse the prevalence of liver involvement and related factors in HIV-infected patients with early syphilis (&lt;2 years). Liver involvement was defined as an elevation above normal ranges of alanine transaminase, aspartate aminotransferase, gamma-glutamyltransferase and/or alkaline phosphatase during early syphilis, or doubling of previous levels in patients with liver enzyme elevation before syphilis. We undertook a multicentre study and of the 147 cases, 86.4% were men who had sex with men, and the diagnoses of syphilis and HIV infection were coincident in 48 (32.7%). Liver involvement was detected in 45 (30.6%) and the only related factor was a rapid plasma reagin (RPR) titre ≥1/64 (odds ratio 3.76; 95% confidence interval 1.3–10.5; <italic>P</italic> = 0.012). In conclusion, liver involvement occurs in around one-third of HIV-infected patients with early syphilis and is associated with high RPR levels. Syphilis should be included in the differential diagnosis of liver enzyme elevation in HIV-infected patients.</p>
         </abstract>
         <kwd-group>
            <title>Keywords</title>
            <kwd>
               <italic>Treponema pallidum</italic>
            </kwd>
            <kwd>syphilis</kwd>
            <kwd>HIV</kwd>
            <kwd>liver enzymes</kwd>
            <kwd>hepatitis</kwd>
            <kwd>early syphilis</kwd>
         </kwd-group>
      </article-meta>
   </front>
   <body>
      <sec id="s1" sec-type="intro">
         <title>INTRODUCTION</title>
         <p>Liver enzyme elevation is common in HIV-infected patients.<sup>
               <xref ref-type="bibr" rid="IJSA-12-113C1">1</xref>,<xref ref-type="bibr" rid="IJSA-12-113C2">2</xref>
            </sup> Although this elevation was traditionally due to opportunistic events like <italic>Mycobacterium tuberculosis</italic>, <italic>Cryptosporidium complex,</italic> lymphomas or Kaposi sarcoma, liver enzyme elevation since the introduction of combination antiretroviral therapy (cART) is more usually secondary to viral hepatitis, potentially hepatotoxic drugs (as are many of the antiretrovirals), alcohol and hepatic steatosis.<sup>
               <xref ref-type="bibr" rid="IJSA-12-113C1">1</xref>–<xref ref-type="bibr" rid="IJSA-12-113C3">3</xref>
            </sup> Liver involvement has also been seen in patients who are co-infected with syphilis during the early stages of the disease,<sup>
               <xref ref-type="bibr" rid="IJSA-12-113C4">4</xref>–<xref ref-type="bibr" rid="IJSA-12-113C8">8</xref>
            </sup> though only 23 cases of syphilitic hepatitis have been reported.<sup>
               <xref ref-type="bibr" rid="IJSA-12-113C4">4</xref>,<xref ref-type="bibr" rid="IJSA-12-113C6">6</xref>,<xref ref-type="bibr" rid="IJSA-12-113C8">8</xref>–<xref ref-type="bibr" rid="IJSA-12-113C11">11</xref>
            </sup> In fact, the incidence of acute hepatitis during early syphilis infection and the factors associated with syphilitic hepatitis among HIV-infected patients are currently unknown. Accordingly, we aimed to analyse the prevalence of liver involvement and related factors in HIV-infected patients diagnosed with early syphilis.</p>
      </sec>
      <sec id="s2" sec-type="methods">
         <title>PATIENTS AND METHODS</title>
         <p>We conducted a multicentre case series study of patients co-infected with HIV and syphilis. Databases from three Spanish hospitals were first reviewed to identify all HIV-infected patients who were diagnosed with early syphilis infection (duration &lt;2 years) from January 2004 to December 2010. The diagnosis of syphilis was based on positive serological test results, including a non-treponemal antibody test and a specific treponemal antibody test. In addition, to be included in the study, all patients had to have had serological liver tests (transaminases, alkaline phosphatase and bilirubin) carried out around the time of the syphilis diagnosis and at least once more before and/or after the diagnosis of syphilis at the time points defined as follows: ‘before’ (3–9 months before the diagnosis of syphilis), ‘during’ (between 12 weeks before and 2 weeks after the diagnosis of syphilis) and ‘after’ (3–9 months after the diagnosis and treatment of syphilis). Patients with acute hepatitis due to viral hepatitis or any other cause during the episode of syphilis, patients without completed treatment for syphilis and those with missing data were excluded from the analysis. The changes in liver test results for the ‘before-to-during’ and ‘during-to-after’ periods for each patient who had paired data were calculated. Liver involvement was defined by rises above the normal range in the levels of aspartate aminotransferase, alanine transaminase (ALT), gamma-glutamyltransferase (GGT) and/or alkaline phosphatase during the syphilis infection or doubling of the previous value in patients with values that were already high before the diagnosis of syphilis. Various different episodes of syphilis in the same patient were included, provided correct treatment and response were confirmed for the first episode (with fall in rapid plasma reagin RPR titres to negative or less than or equal to half the RPR at treatment and epidemiological exposure to syphilis).</p>
         <p>The qualitative variables are expressed in percentages and the associations were analysed with the Chi square test (χ<sup>2</sup>) or Fischer's exact test. The quantitative variables are expressed as the mean (interquartile range) and the differences were analysed with the Student's <italic>t-</italic>test after determining that the quantitative variables followed a normal distribution (Kolmogorov–Smirnov test). When there were more than two groups to compare, a one-way or multi-way analysis of variance (ANOVA) was used. The multivariate analysis for variables related with liver involvement was done with the Cox proportional hazards model. The odds ratios (ORs) were determined and 95% confidence intervals (CIs) calculated for significant variables. In all cases two-tailed tests were conducted and significance was set at <italic>P</italic> &lt; 0.05. The analyses were done with SPSS 17.0.0 (SPSS, Inc., Chicago, IL, USA).</p>
      </sec>
      <sec id="s3" sec-type="results">
         <title>RESULTS</title>
         <p>During the study period 155 episodes of syphilis were diagnosed; five cases were excluded due to lack of data and three due to coincident acute viral hepatitis. Therefore, the final study included 147 cases. Most (86.4%) were men who had sex with men (MSM), with a mean age of 38.7 years, and the diagnoses of syphilis and HIV infection were coincident in 48 (32.7%) patients. At syphilis diagnosis, the mean CD4 cell count was 497 cells/mm<sup>3</sup>, 70.7% of those with prior known HIV infection were on cART and 64.2% of these had an undetectable HIV viral load. Liver involvement during syphilis was detected in 45 (30.6%) patients, and only one of these presented with symptomatic hepatitis, mainly vomiting and jaundice. Liver involvement was more frequent in patients with a coincident diagnosis of HIV and syphilis, and in cases with any symptoms of syphilis (Table <xref ref-type="table" rid="IJSA-12-113TB1">1</xref>), but the only factor associated with this abnormality in multivariate analysis was an RPR titre ≥1/64 (OR 3.76; 95% CI 1.3–10.5; <italic>P</italic> = 0.012). No association was found with CD4 cell count, HIV viral load, chronic co-infection with hepatitis viruses or clinical presentation of syphilis (asymptomatic [early latent], chancre or secondary syphilis).
<table-wrap id="IJSA-12-113TB1" position="float">
               <label>Table 1</label>
               <caption>
                  <p>Comparison of patients with and without liver involvement (univariate analysis)</p>
               </caption>
               <table frame="hsides" rules="groups">
                  <colgroup span="1">
                     <col align="left" span="1"/>
                     <col align="left" span="1"/>
                     <col align="left" span="1"/>
                     <col align="char" char="." span="1"/>
                  </colgroup>
                  <thead>
                     <tr>
                        <th colspan="1" rowspan="1"/>
                        <th align="left" colspan="1" rowspan="1">LI<break/>
                           <italic>n</italic> = 45 (80.6%)</th>
                        <th align="left" colspan="1" rowspan="1">No LI<break/> <italic>n</italic> = 102 (69.4)</th>
                        <th align="left" colspan="1" rowspan="1">
                           <italic>P</italic>
                        </th>
                     </tr>
                  </thead>
                  <tbody>
                     <tr>
                        <td colspan="1" rowspan="1">Age (years)</td>
                        <td colspan="1" rowspan="1">39.1 (31.8–46.6)</td>
                        <td colspan="1" rowspan="1">38.5 (30.4–45.2)</td>
                        <td colspan="1" rowspan="1">0.7</td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1">Co-infection HBV/HCV</td>
                        <td colspan="1" rowspan="1">10 (22.2)</td>
                        <td colspan="1" rowspan="1">16 (15.6)</td>
                        <td colspan="1" rowspan="1">0.2</td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1">On prior ART*</td>
                        <td colspan="1" rowspan="1">18 (75.0)</td>
                        <td colspan="1" rowspan="1">52 (69.3)</td>
                        <td colspan="1" rowspan="1">0.2</td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1">VL &lt;50 copies/mL<sup>†</sup>
                        </td>
                        <td colspan="1" rowspan="1">9 (50.0)</td>
                        <td colspan="1" rowspan="1">36 (69.2)</td>
                        <td colspan="1" rowspan="1">0.4</td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1">CD4 cells/mm<sup>3</sup>
                        </td>
                        <td colspan="1" rowspan="1">494 (322–658)</td>
                        <td colspan="1" rowspan="1">498 (327–617)</td>
                        <td colspan="1" rowspan="1">0.9</td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1">Coincident diagnosis</td>
                        <td colspan="1" rowspan="1">21 (46.6)</td>
                        <td colspan="1" rowspan="1">27 (26.4)</td>
                        <td colspan="1" rowspan="1">0.02</td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1">First episode</td>
                        <td colspan="1" rowspan="1">35 (77.7)</td>
                        <td colspan="1" rowspan="1">75 (73.5)</td>
                        <td colspan="1" rowspan="1">0.6</td>
                     </tr>
                     <tr>
                        <td colspan="4" rowspan="1">
                           <bold>Clinical presentation</bold>
                        </td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1"> Asymptomatic</td>
                        <td colspan="1" rowspan="1">6 (13.3)</td>
                        <td colspan="1" rowspan="1">31 (30.3)</td>
                        <td colspan="1" rowspan="1">0.03</td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1"> Chancre</td>
                        <td colspan="1" rowspan="1">8 (17.7)</td>
                        <td colspan="1" rowspan="1">15 (14.7)</td>
                        <td colspan="1" rowspan="1">0.6</td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1"> Secondary syphilis</td>
                        <td colspan="1" rowspan="1">28 (62.2)</td>
                        <td colspan="1" rowspan="1">46 (45.0)</td>
                        <td colspan="1" rowspan="1">0.07</td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1"> Other</td>
                        <td colspan="1" rowspan="1">3 (6.6)</td>
                        <td colspan="1" rowspan="1">8 (7.8)</td>
                        <td colspan="1" rowspan="1">1.0</td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1">RPR≥1/64</td>
                        <td colspan="1" rowspan="1">20 (44.4)</td>
                        <td colspan="1" rowspan="1">25 (24.5)</td>
                        <td colspan="1" rowspan="1">0.007</td>
                     </tr>
                  </tbody>
               </table>
               <table-wrap-foot>
                  <fn>
                     <p>LI = liver involvement; HBV/HCV = hepatitis B virus/hepatitis C virus; ART = antiretroviral therapy; VL = viral load; RPR = rapid plasma reagin</p>
                  </fn>
                  <fn>
                     <p>Quantitative variables: mean (IQR). Qualitative variables: <italic>n</italic> (%)</p>
                  </fn>
                  <fn>
                     <p>*Of those with prior HIV diagnosis</p>
                  </fn>
                  <fn>
                     <p>
                        <sup>†</sup>Of those on ART</p>
                  </fn>
               </table-wrap-foot>
            </table-wrap>
         </p>
         <p>Figures <xref ref-type="fig" rid="IJSA-12-113F1">1</xref>–<xref ref-type="fig" rid="IJSA-12-113F4">4</xref> show the course of the liver enzymes (ALT, alkaline phosphatase, GGT and bilirubin) of all 45 patients with liver involvement; note the rise in these enzymes coinciding with the diagnosis of syphilis and their subsequent fall.
<fig id="IJSA-12-113F1" position="float">
               <label>Figure 1</label>
               <caption>
                  <p>Course of alanine transaminase (UI/mL) in all patients with liver involvement</p>
               </caption>
               <graphic position="float" xlink:href="10.1177_0956462412472316-fig1.tif" xlink:type="simple"/>
            </fig>
            <fig id="IJSA-12-113F2" position="float">
               <label>Figure 2</label>
               <caption>
                  <p>Course of alkaline phosphatase (UI/mL) in all patients with liver involvement</p>
               </caption>
               <graphic position="float" xlink:href="10.1177_0956462412472316-fig2.tif" xlink:type="simple"/>
            </fig>
            <fig id="IJSA-12-113F3" position="float">
               <label>Figure 3</label>
               <caption>
                  <p>Course of gamma-glutamyltransferase (UI/mL) in all patients with liver involvement</p>
               </caption>
               <graphic position="float" xlink:href="10.1177_0956462412472316-fig3.tif" xlink:type="simple"/>
            </fig>
            <fig id="IJSA-12-113F4" position="float">
               <label>Figure 4</label>
               <caption>
                  <p>Course of bilirubin (mg/dL) in all patients with liver involvement</p>
               </caption>
               <graphic position="float" xlink:href="10.1177_0956462412472316-fig4.tif" xlink:type="simple"/>
            </fig>
         </p>
      </sec>
      <sec id="s4" sec-type="discussion">
         <title>DISCUSSION</title>
         <p>The results of this study show that one-third of HIV-infected patients diagnosed with early syphilis had liver involvement, with the only factor associated with this event being an RPR titre ≥1/64.</p>
         <p>Although Paracelsus described liver involvement due to syphilis in the general population in 1585, only a few data have actually been published, with the largest recent series comprising 17 cases.<sup>
               <xref ref-type="bibr" rid="IJSA-12-113C12">12</xref>
            </sup> Liver involvement has traditionally been described as a disproportionate increase in alkaline phosphatase in the context of secondary syphilis with rash.<sup>
               <xref ref-type="bibr" rid="IJSA-12-113C13">13</xref>,<xref ref-type="bibr" rid="IJSA-12-113C14">14</xref>
            </sup> In HIV-infected patients it was not until the last decade that data appeared about liver involvement in syphilis.<sup>
               <xref ref-type="bibr" rid="IJSA-12-113C4">4</xref>–<xref ref-type="bibr" rid="IJSA-12-113C8">8</xref>
            </sup> The two largest series include seven and 12 cases, respectively,<sup>
               <xref ref-type="bibr" rid="IJSA-12-113C4">4</xref>,<xref ref-type="bibr" rid="IJSA-12-113C8">8</xref>
            </sup> reporting a prevalence of liver involvement in HIV-infected patients with early syphilis of around 40%.<sup>
               <xref ref-type="bibr" rid="IJSA-12-113C8">8</xref>
            </sup> As in our study, liver involvement due to syphilis in these series is similar to that described for the general population, with a marked increase in alkaline phosphatase and a slightly lower rise in transaminases, with generalized rash being the most common associated symptom.<sup>
               <xref ref-type="bibr" rid="IJSA-12-113C4">4</xref>,<xref ref-type="bibr" rid="IJSA-12-113C13">13</xref>,<xref ref-type="bibr" rid="IJSA-12-113C14">14</xref>
            </sup> In our series, 51.9% of patients presented with secondary syphilis with generalized rash, with no difference between those with liver involvement and those without. Of note too, was the fact that syphilis was asymptomatic in over one-third of our cases, with the diagnosis made from routine serological tests.</p>
         <p>Concerning the factors associated with liver involvement in HIV-infected patients with early syphilis, Mullick <italic>et al.</italic>
            <sup>
               <xref ref-type="bibr" rid="IJSA-12-113C4">4</xref>
            </sup> found a correlation with a higher CD4 cell count, suggesting that host immune inflammatory response in the periportal region might be a factor in the development of clinical symptoms of syphilitic hepatitis. In our series, the immunological status was similar in patients with and without liver involvement, probably because a considerable percentage of our cases occurred in patients under regular follow-up and receiving cART, with good immunovirological status. Crum-Cianflone <italic>et al.</italic>
            <sup>
               <xref ref-type="bibr" rid="IJSA-12-113C8">8</xref>
            </sup> reported a greater likelihood of syphilitic hepatitis in patients who had had HIV infection for longer. No association was found in our series with the duration of HIV infection, the CD4 cell count, chronic co-infection with hepatotropic viruses or with the clinical presentation of syphilis (asymptomatic, chancre or secondary). Like Mullick <italic>et al.</italic>,<sup>
               <xref ref-type="bibr" rid="IJSA-12-113C4">4</xref>
            </sup> we also saw a correlation with high RPR titres, which may represent a higher treponemal load with potential risk of organ involvement. As seen in other series,<sup>
               <xref ref-type="bibr" rid="IJSA-12-113C4">4</xref>,<xref ref-type="bibr" rid="IJSA-12-113C8">8</xref>
            </sup> after standard treatment of syphilis the liver enzyme levels returned to baseline values in all cases.</p>
         <p>To date this is the largest reported series of HIV-infected patients with early syphilis and liver involvement. Based on our findings, syphilis should be included in the differential diagnosis of liver enzyme elevation in HIV-infected patients and, as indicated in the guidelines, patients should be screened for syphilis on diagnosis of their HIV infection as well as periodically afterwards and preventive measures encouraged.</p>
         <p>
            <bold>Conflict of interest:</bold> None declared.</p>
      </sec>
   </body>
   <back>
      <ref-list>
         <title>REFERENCES</title>
         <ref id="IJSA-12-113C1">
            <label>1</label>
            <citation citation-type="journal" xlink:type="simple">
               <name name-style="western">
                  <surname>Poles</surname>
                  <given-names>MA</given-names>
               </name>, <name name-style="western">
                  <surname>Lew</surname>
                  <given-names>EA</given-names>
               </name>, <name name-style="western">
                  <surname>Dieterich</surname>
                  <given-names>DT</given-names>
               </name>. <article-title>Diagnosis and treatment of hepatic disease in patients with HIV</article-title>. <source>Gastroenterol Clin North Am</source>
               <year>1997</year>;<volume>26</volume>:<fpage>291</fpage>–<lpage>321</lpage>
            </citation>
         </ref>
         <ref id="IJSA-12-113C2">
            <label>2</label>
            <citation citation-type="journal" xlink:type="simple">
               <name name-style="western">
                  <surname>Ogedegbe</surname>
                  <given-names>AO</given-names>
               </name>, <name name-style="western">
                  <surname>Sulkowski</surname>
                  <given-names>MS</given-names>
               </name>. <article-title>Antiretroviral-associated liver injury</article-title>. <source>Clin Liver Dis</source>
               <year>2003</year>;<volume>7</volume>:<fpage>475</fpage>–<lpage>99</lpage>
            </citation>
         </ref>
         <ref id="IJSA-12-113C3">
            <label>3</label>
            <citation citation-type="journal" xlink:type="simple">
               <name name-style="western">
                  <surname>Wnuk</surname>
                  <given-names>AM</given-names>
               </name>. <article-title>Liver damage in HIV-infected patients</article-title>. <source>Med Sci Monit</source>
               <year>2001</year>;<volume>7</volume>:<fpage>729</fpage>–<lpage>36</lpage>
            </citation>
         </ref>
         <ref id="IJSA-12-113C4">
            <label>4</label>
            <citation citation-type="journal" xlink:type="simple">
               <name name-style="western">
                  <surname>Mullick</surname>
                  <given-names>CJ</given-names>
               </name>, <name name-style="western">
                  <surname>Liappis</surname>
                  <given-names>AP</given-names>
               </name>, <name name-style="western">
                  <surname>Benator</surname>
                  <given-names>DA</given-names>
               </name>, <name name-style="western">
                  <surname>Roberts</surname>
                  <given-names>AD</given-names>
               </name>, <name name-style="western">
                  <surname>Parenti</surname>
                  <given-names>DM</given-names>
               </name>, <name name-style="western">
                  <surname>Simon</surname>
                  <given-names>GL</given-names>
               </name>. <article-title>Syphilitic hepatitis in HIV-infected patients: a report of 7 cases and review of the literature</article-title>. <source>Clin Infect Dis</source>
               <year>2004</year>;<volume>39</volume>:<fpage>100</fpage>–<lpage>5</lpage>
            </citation>
         </ref>
         <ref id="IJSA-12-113C5">
            <label>5</label>
            <citation citation-type="journal" xlink:type="simple">
               <name name-style="western">
                  <surname>De Miguel</surname>
                  <given-names>A</given-names>
               </name>, <name name-style="western">
                  <surname>Benedicto</surname>
                  <given-names>JR</given-names>
               </name>. <article-title>Hepatitis sifilítica: una patología ‘poco frecuente</article-title>’. <source>Mediafam</source>
               <year>2002</year>;<volume>3</volume>:<fpage>226</fpage>–<lpage>8</lpage>
            </citation>
         </ref>
         <ref id="IJSA-12-113C6">
            <label>6</label>
            <citation citation-type="journal" xlink:type="simple">
               <name name-style="western">
                  <surname>Cooper</surname>
                  <given-names>C</given-names>
               </name>, <name name-style="western">
                  <surname>MacPherson</surname>
                  <given-names>P</given-names>
               </name>, <name name-style="western">
                  <surname>Angel</surname>
                  <given-names>JB</given-names>
               </name>. <article-title>Liver toxicity resulting from syphilis and Jarish-Herxheimer reaction in cases of coinfection with HIV and hepatitis C virus</article-title>. <source>Clin Infect Dis</source>
               <year>2005</year>;<volume>40</volume>:<fpage>1211</fpage>–<lpage>2</lpage>
            </citation>
         </ref>
         <ref id="IJSA-12-113C7">
            <label>7</label>
            <citation citation-type="journal" xlink:type="simple">
               <name name-style="western">
                  <surname>Albandea Moreno</surname>
                  <given-names>C</given-names>
               </name>, <name name-style="western">
                  <surname>Aguilar Urbano</surname>
                  <given-names>VM</given-names>
               </name>, <name name-style="western">
                  <surname>Rivera Irigoin</surname>
                  <given-names>R</given-names>
               </name>, <etal/>
               <article-title>Syphilitic hepatitis: case report</article-title>. <source>Rev Esp Enferm Dig</source>
               <year>2009</year>;<volume>101</volume>:<fpage>813</fpage>–<lpage>9</lpage>
            </citation>
         </ref>
         <ref id="IJSA-12-113C8">
            <label>8</label>
            <citation citation-type="journal" xlink:type="simple">
               <name name-style="western">
                  <surname>Crum-Cianflone</surname>
                  <given-names>N</given-names>
               </name>, <name name-style="western">
                  <surname>Weekes</surname>
                  <given-names>J</given-names>
               </name>, <name name-style="western">
                  <surname>Bavaro</surname>
                  <given-names>M</given-names>
               </name>. <article-title>Syphilitic hepatitis among HIV-infected patients</article-title>. <source>Int J STD AIDS</source>
               <year>2009</year>;<volume>20</volume>:<fpage>278</fpage>–<lpage>84</lpage>
            </citation>
         </ref>
         <ref id="IJSA-12-113C9">
            <label>9</label>
            <citation citation-type="journal" xlink:type="simple">
               <name name-style="western">
                  <surname>Dooley</surname>
                  <given-names>DP</given-names>
               </name>, <name name-style="western">
                  <surname>Tomski</surname>
                  <given-names>S</given-names>
               </name>. <article-title>Syphilitic pneumonitis in an HIV-infected patient</article-title>. <source>Chest</source>
               <year>1994</year>;<volume>105</volume>:<fpage>629</fpage>–<lpage>31</lpage>
            </citation>
         </ref>
         <ref id="IJSA-12-113C10">
            <label>10</label>
            <citation citation-type="journal" xlink:type="simple">
               <name name-style="western">
                  <surname>Sabbatani</surname>
                  <given-names>S</given-names>
               </name>, <name name-style="western">
                  <surname>Manfredi</surname>
                  <given-names>R</given-names>
               </name>, <name name-style="western">
                  <surname>Attard</surname>
                  <given-names>L</given-names>
               </name>, <name name-style="western">
                  <surname>Salfi</surname>
                  <given-names>N</given-names>
               </name>, <name name-style="western">
                  <surname>Chiodo</surname>
                  <given-names>F</given-names>
               </name>. <article-title>Secondary syphilis presenting with acute severe hepatic involvement in a patient with undiagnosed HIV disease</article-title>. <source>AIDS Patient Care STD</source>
               <year>2005</year>;<volume>19</volume>:<fpage>545</fpage>–<lpage>9</lpage>
            </citation>
         </ref>
         <ref id="IJSA-12-113C11">
            <label>11</label>
            <citation citation-type="journal" xlink:type="simple">
               <name name-style="western">
                  <surname>Adachi</surname>
                  <given-names>E</given-names>
               </name>, <name name-style="western">
                  <surname>Koibuchi</surname>
                  <given-names>T</given-names>
               </name>, <name name-style="western">
                  <surname>Okame</surname>
                  <given-names>M</given-names>
               </name>, <etal/>
               <article-title>Case of secondary syphilis presenting with unusual complications: syphilitic proctitis, gastritis, and hepatitis</article-title>. <source>J Clin Microbiol</source>
               <year>2011</year>;<volume>49</volume>:<fpage>4394</fpage>–<lpage>6</lpage>
            </citation>
         </ref>
         <ref id="IJSA-12-113C12">
            <label>12</label>
            <citation citation-type="journal" xlink:type="simple">
               <name name-style="western">
                  <surname>Feher</surname>
                  <given-names>J</given-names>
               </name>, <name name-style="western">
                  <surname>Somogyi</surname>
                  <given-names>T</given-names>
               </name>, <name name-style="western">
                  <surname>Timmer</surname>
                  <given-names>M</given-names>
               </name>, <name name-style="western">
                  <surname>Józsa</surname>
                  <given-names>L</given-names>
               </name>. <article-title>Early syphilitic hepatitis</article-title>. <source>Lancet</source>
               <year>1975</year>;<volume>2</volume>:<fpage>896</fpage>–<lpage>9</lpage>
            </citation>
         </ref>
         <ref id="IJSA-12-113C13">
            <label>13</label>
            <citation citation-type="journal" xlink:type="simple">
               <name name-style="western">
                  <surname>Baker</surname>
                  <given-names>AL</given-names>
               </name>, <name name-style="western">
                  <surname>Kaplan</surname>
                  <given-names>MM</given-names>
               </name>, <name name-style="western">
                  <surname>Wolfe</surname>
                  <given-names>HJ</given-names>
               </name>, <name name-style="western">
                  <surname>McGowan</surname>
                  <given-names>JA</given-names>
               </name>. <article-title>Liver disease associated with early syphilis</article-title>. <source>N Engl J Med</source>
               <year>1971</year>;<volume>284</volume>:<fpage>1422</fpage>–<lpage>3</lpage>
            </citation>
         </ref>
         <ref id="IJSA-12-113C14">
            <label>14</label>
            <citation citation-type="journal" xlink:type="simple">
               <name name-style="western">
                  <surname>Campisi</surname>
                  <given-names>D</given-names>
               </name>, <name name-style="western">
                  <surname>Whitcomb</surname>
                  <given-names>C</given-names>
               </name>. <article-title>Liver disease in early syphilis</article-title>. <source>Arch Intern Med</source>
               <year>1979</year>;<volume>139</volume>:<fpage>365</fpage>–<lpage>6</lpage>
            </citation>
         </ref>
      </ref-list>
   </back>
</article>